RxDoctor Payments Data

Teresa Harris

Women's Health · Dover, DENPI 1134297286

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 113 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Mayne Pharma Commercial LLC at 27.1% of the total. Reporting peaked in 2021 at $1,045 and has fallen 97.2% since, to $30 in 2025. Among women's health clinicians in DE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,515in general payments, 2019–2025

Across 113 payments — averaging $22.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mayne Pharma Commercial LLC$681
  • Evofem Biosciences, Inc.$253
  • Myovant Sciences Inc.$227
  • AbbVie$226
  • Daiichi Sankyo Inc.$184
  • Amgen$179
  • plus $766 from 17 others

What the payments were for

  • Food & beverage$2,515100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,515 in reported general payments places this provider in the 90th percentile of 29 women's health providers in Delaware.

See all women's health providers in Delaware

Other women's health in Dover

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →